Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes

Area of Science:

• Molecular Biology
• Oncology
• Neuroscience

Background:

• The transcription factor RFX7 is recurrently mutated in lymphoid neoplasms and is recognized as a tumor suppressor.
• Previous studies indicated potential roles for RFX7 in neurological and metabolic disorders, and its response to p53 signaling and cellular stress.
• RFX7 target genes are dysregulated across various cancer types, but its comprehensive network and function remain unclear.

Purpose of the Study:

• To elucidate the comprehensive target gene network of RFX7.
• To investigate the role of RFX7 in tumor suppression and neurological disorders.
• To understand the mechanistic link between RFX7, p53 signaling, and target gene activation.

Main Methods:

• Generation of RFX7 knock-out cell lines.
• Application of a multi-omics approach integrating transcriptome, cistrome, and proteome data.
• Analysis of RFX7 target genes and their regulation by p53 signaling.

Main Results:

• Identification of novel RFX7 target genes.
• Association of identified targets with RFX7's tumor suppressor functions.
• Evidence supporting RFX7's role in neurological disorders and its activation via p53 signaling.

Conclusions:

• RFX7 plays a significant role as a tumor suppressor, with implications beyond hematological malignancies.
• The study provides novel insights into RFX7's target gene network and its involvement in neurological conditions.
• RFX7 acts as a key mediator for activating specific genes in response to p53 signaling.